Trust Signals
Written by the FormBlends Medical Team. Reviewed against publicly available regulatory filings, independent third-party testing reports, and company quality documentation. No affiliate relationships with any supplier named on this page. Last updated: May 29, 2026.
Key Takeaways
- GL Biochem (Shanghai) is one of the largest peptide CDMOs globally, supplying downstream US and European brands; most buyers interact with GL Biochem indirectly through resellers.
- Hybio Pharmaceutical (Shenzhen, SZ: 300199) holds FDA Drug Master Files for specific peptide APIs and manufactures commercially approved peptide drugs, making it categorically different from research-grade suppliers.
- A purity percentage on a supplier PDF is not a certificate of analysis. A real COA includes a lot-traceable HPLC chromatogram and a mass spectrometry result confirming sequence identity.
- Research-grade peptide suppliers operate outside FDA oversight. Independent HPLC and MS testing by the buyer is the only reliable quality check.
- Lyophilized peptides tolerate short-duration ambient shipping better than solutions, but methionine, cysteine, and tryptophan-containing sequences are vulnerable to oxidative degradation at any temperature if exposed to air or light.
Direct Answer: What Is the Best Chinese Peptide Company?
For pharmaceutical-grade API supply, Hybio Pharmaceutical and Bachem's Chinese sourcing partners lead on regulatory compliance. For research-grade supply, GL Biochem and Scilight Peptide (Beijing) are the most cited facilities by downstream Western brands that publish their own independent testing. No single company is best across all use cases, and the supplier's COA alone cannot be trusted without independent mass spectrometry verification.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of Contents
- The Chinese Peptide Industry Landscape
- Ranked: Leading Chinese Peptide Companies
- Evidence Ledger: Quality Claims Graded
- What Most Pages Get Wrong: COA Literacy
- Regulatory Reality in the US and EU
- Chemistry Behind Storage and Stability Rules
- Head-to-Head: Chinese Suppliers vs. Western Alternatives
- Operational Guide: How to Evaluate Any Chinese Peptide Supplier
- FAQ
- Sources
- Footer Disclaimers
What Does the Chinese Peptide Industry Actually Look Like?
China accounts for a substantial share of global peptide API production, driven by lower synthesis costs and large-scale SPPS (solid-phase peptide synthesis) infrastructure concentrated in Shanghai, Beijing, Shenzhen, and Chengdu. The market divides cleanly into three tiers:
Tier 1: Pharmaceutical CDMOs. Companies like Hybio Pharmaceutical, ScinoPharm (Taiwan, with mainland operations), and Asymchem manufacture peptide APIs for licensed drug products. These facilities operate under GMP, hold FDA Drug Master Files for specific sequences, and do not sell directly to individual researchers.
Tier 2: Research-Grade CDMOs and Catalog Suppliers. Companies like GL Biochem (Shanghai), Scilight Peptide (Beijing), and ChinaPeptides supply custom and catalog peptides to academic labs, biotech companies, and US or European resellers. Quality varies widely within this tier and is not regulated by any body equivalent to the FDA for research purposes.
Tier 3: Small Brokers and Repackagers. Numerous Alibaba-listed vendors source from Tier 2 or unknown manufacturers and repackage under their own labels. This tier has the highest risk of mislabeling, contamination, and fraudulent COAs.
Ranked: Leading Chinese Peptide Companies by Use Case
1. GL Biochem (Shanghai) -- Best for Research-Grade Volume
GL Biochem is ISO 9001 certified and one of the world's largest custom peptide synthesis facilities by output. It supplies many US and European brands that independently verify their products. GL Biochem produces peptides by SPPS and offers HPLC purification to specified purity thresholds, with mass spectrometry confirmation available per lot. It does not hold FDA drug approvals for its research catalog but operates under Chinese national quality standards. Its relevance to US buyers is largely indirect, as a manufacturing backbone for branded suppliers.
Transparency rating: Moderate. Lot-specific HPLC chromatograms available on request for custom orders. Catalog COA depth varies.
2. Hybio Pharmaceutical (Shenzhen) -- Best for Pharmaceutical API
Hybio (Shenzhen Stock Exchange: 300199) is a publicly listed pharmaceutical company manufacturing approved peptide drugs including oxytocin, terlipressin, and thymalfasin for commercial markets. It holds FDA Drug Master Files for select APIs and operates GMP-certified facilities. It is not a research peptide supplier. Its significance is that downstream compounding pharmacies and licensed manufacturers sourcing peptide APIs through legitimate channels may ultimately source from Hybio or its equivalents.
Transparency rating: High for regulated channels. Not accessible to individual researchers.
3. Scilight Peptide (Beijing) -- Best for Academic Custom Synthesis
Scilight (also known as SciLight Biotechnology) focuses on custom peptide synthesis for academic research. It is regularly cited in Chinese academic literature as a synthesis provider, which provides some indirect third-party verification of its capabilities. It offers HPLC and MS QC data per order. Scale is smaller than GL Biochem, making it more suitable for small academic runs than large commercial supply.
Transparency rating: Moderate to high for custom orders with documented QC.
4. ChinaPeptides (Shanghai) -- Best for Catalog Research Peptides
ChinaPeptides maintains a large catalog and offers documented HPLC purity. Independent verification data from Western buyers is less consistently published than for GL Biochem-sourced products. Suitable for academic use where sequence confirmation by the end user's own MS is feasible.
Transparency rating: Moderate. Buyer verification is strongly recommended.
5. Bachem (Swiss CDMO, Chinese API Sourcing) -- Best for Pharmaceutical-Grade with Western QC Overlay
Bachem is a Swiss company that manufactures and sources peptide APIs with GMP standards applicable to drug manufacturing. It uses Chinese manufacturing infrastructure for some API steps but applies its own QC overlay. For buyers requiring USP-comparable quality documentation, Bachem-sourced material with Bachem's own COA is a higher-confidence option than direct Chinese research supplier COAs. Cost is substantially higher.
Transparency rating: High. Regulatory-grade documentation available.
Evidence Ledger: Quality and Purity Claims Graded
| Claim | Best Evidence Type | Effect Direction | Confidence | Key Caveat |
|---|---|---|---|---|
| GL Biochem supplies many US-branded peptide resellers | Industry reports, reseller disclosures | Confirmed directionally | Moderate | Not all resellers disclose manufacturing origin |
| Hybio holds FDA Drug Master Files for peptide APIs | FDA DMF database (publicly searchable) | Confirmed | High | DMF covers specific named APIs, not all Hybio products |
| Research-grade Chinese peptides frequently fail independent MS verification | Independent testing reports by US resellers (e.g., Janoshik lab reports cited by vendors) | Failure rate is meaningful but variable by supplier | Low to Moderate | Published failures are self-selected; non-published failures are unknown |
| Lyophilized peptides tolerate short ambient shipping better than solutions | Peptide chemistry literature, ICH Q1A stability guidance | Directionally confirmed | Moderate | Depends heavily on peptide sequence and packaging integrity |
| Supplier-provided purity percentages without chromatograms are unreliable | Analytical chemistry consensus, FDA guidance on impurity testing | Confirmed as a risk | High (as a risk statement) | Does not mean all supplier COAs are fabricated, only unverifiable |
| ChP purity methods are not directly comparable to USP methods | USP/ChP pharmacopoeial standards documentation | Confirmed | High | Method bridging can resolve differences but is rarely done at research grade |
What Most Pages Get Wrong: COA Literacy and the Purity Percentage Trap
A legitimate certificate of analysis for a research peptide contains all of the following:
- Lot number that matches the vial label and is traceable to the specific production batch
- HPLC chromatogram (not just the calculated percentage), showing peak shape, retention time, and the impurity profile
- Mass spectrometry result confirming the observed molecular weight matches the theoretical molecular weight of the stated sequence, confirming sequence identity
- Endotoxin result (limulus amebocyte lysate or equivalent) if the peptide is intended for injectable use, with a specific EU per mg value
- Water content (Karl Fischer titration) if weight-based dosing accuracy matters, because lyophilized peptides can retain variable moisture that affects true peptide content per milligram
A document showing "Purity: 98.5% by HPLC" with no chromatogram and no lot-traceable mass spec data is marketing material. Many Alibaba-tier Chinese suppliers provide exactly this. Higher-tier suppliers like GL Biochem and Scilight can provide full documentation on request; the question is whether you request it and verify it.
Independent verification means sending your received vial to a contract analytical lab (Janoshik, Colmaric Analyticals, or equivalent) for HPLC and MS. This costs roughly $50 to $150 per sample and is the only way to confirm what you received matches what was claimed.
What Is the Regulatory Reality for Chinese Peptides Entering the US?
Most Chinese peptide suppliers selling to US researchers operate in a regulatory gray zone. The peptides are not approved drugs, they are often listed as "research use only" or "not for human use," and they are subject to FDA import scrutiny under the Food, Drug, and Cosmetic Act if they are perceived as drug products or drug precursors.
FDA has issued import alerts for specific peptide substances and for unapproved drug products. US Customs can and does hold or seize shipments. The probability of seizure varies by the specific peptide, declared value, country of origin labeling, and current enforcement priorities, none of which are predictable by the buyer.
For compounding pharmacies, the regulatory bar is categorically higher. A 503A or 503B compounder must source APIs from FDA-registered facilities meeting current good manufacturing practice standards. Using peptide APIs sourced from an unregistered Chinese research supplier in a US compounding pharmacy is a violation of federal law.
Hybio Pharmaceutical and a small number of other Chinese pharmaceutical manufacturers do appear in FDA's DMF database for specific peptide APIs. These are the legitimate pharmaceutical supply chain, not the research market.
Chemistry Behind Storage and Stability Rules
The rule "store peptides at minus 20 degrees Celsius" exists because peptide degradation is governed by two competing chemical processes: hydrolysis and oxidation.
Hydrolysis is the cleavage of peptide bonds by water. The rate of hydrolysis increases with temperature following Arrhenius kinetics: roughly every 10 degrees Celsius increase in temperature increases the reaction rate by a factor of 2 to 3. Lyophilization removes bulk water, dramatically slowing hydrolysis. This is why lyophilized peptides tolerate brief ambient shipping: the substrate for hydrolysis has been mostly removed. Once reconstituted in solution, hydrolysis resumes at its temperature-dependent rate.
Oxidation targets specific residues. Methionine oxidizes to methionine sulfoxide readily in the presence of dissolved oxygen. Cysteine oxidizes to form disulfide bonds (which may be intended or unintended) or further to sulfenic, sulfinic, or sulfonic acid derivatives. Tryptophan is photolytically oxidized by UV light, producing kynurenine and other degradation products. These reactions occur even in lyophilized peptides if the vial headspace contains oxygen, which is why argon or nitrogen backfilling during lyophilization and dark storage matter.
Practical implication: A Chinese supplier shipping lyophilized peptides under standard international courier conditions is not the primary degradation risk if the transit is under roughly 7 to 10 days and the vial is sealed. The risk escalates if the peptide contains methionine, cysteine, or tryptophan, if the vial seal failed, or if customs holds extend transit to weeks at ambient temperature. Request inert gas backfilling (nitrogen or argon headspace) if ordering methionine or cysteine-containing sequences.
Honest Head-to-Head: Chinese Suppliers vs. Western Alternatives
| Dimension | Chinese Research Supplier (e.g., GL Biochem) | Western Research Supplier (e.g., Bachem, PolyPeptide Group) | Who Wins |
|---|---|---|---|
| Cost per mg for custom peptide | Substantially lower, often 40 to 70% less for standard sequences | Higher, especially for GMP-grade material | Chinese supplier |
| Regulatory documentation (DMF, GMP certificates) | Available at Tier 1 only (Hybio, etc.), not at research grade | GMP documentation standard at Bachem, PolyPeptide | Western supplier |
| Turnaround for custom synthesis | Often 1 to 3 weeks for standard sequences | 2 to 6 weeks common at GMP facilities | Chinese supplier |
| Purity verification independence | COA produced by same entity selling the product; not independent | COA produced by same entity; accredited QC labs more common | Slight edge to Western, but neither is truly independent without buyer testing |
| Import and customs reliability (US buyer) | Variable; seizure risk is real for some peptides | Lower risk when shipped from EU or US stock | Western supplier |
| Availability of obscure or novel sequences | High; large synthesis capacity means more catalog breadth | Lower for non-commercial sequences | Chinese supplier |
| Pharmaceutical-grade supply chain | Hybio and equivalents, but not accessible to researchers | Bachem, PolyPeptide accessible to pharma clients | Western supplier for accessible pharmaceutical grade |
Honest verdict: Chinese research-grade suppliers win on cost and catalog breadth. Western pharmaceutical CDMOs win on regulatory documentation and supply chain integrity. For research use where the buyer performs independent verification, the cost argument for Chinese sourcing is real. For any clinical, compounding, or licensed pharmaceutical application, Western GMP-certified sourcing is the only defensible choice.
Operational Guide: How to Evaluate Any Chinese Peptide Supplier Yourself
This is the checklist a skeptical buyer uses. Evaluate each supplier against every item before purchasing.
| Checkpoint | What to Look For | Red Flag |
|---|---|---|
| COA format | Lot-specific HPLC chromatogram plus MS result | Purity percentage only, no chromatogram, no lot number |
| MS result | Observed m/z matches theoretical MW of stated sequence within instrument tolerance (typically within 1 Da) | No MS data provided, or MS data is a generic stock result not labeled with the lot number |
| Endotoxin testing | LAL result below 1 EU per mg for injectable-intent peptides | No endotoxin data for a peptide marketed for injection |
| Water content | Karl Fischer titration result available; true peptide content per mg calculable | Absent; means stated mg amount may overstate actual peptide by 5 to 15% |
| Independent testing by others | Published third-party MS results (e.g., Janoshik reports) matching supplier claims | Supplier is uncited by any independently verified source |
| Regulatory status transparency | Supplier clearly states "research use only" and does not claim pharmaceutical approval it does not hold | Claims GMP or FDA approval without specific documentation |
| Packaging | Sealed vials with inert gas headspace for oxidation-sensitive sequences | Loose powder in unsealed containers, no indication of headspace treatment |
Reconstitution note: When reconstituting lyophilized peptides, use bacteriostatic water (for storage) or sterile water (for immediate use). Acetic acid at 0.1% concentration is recommended for basic peptides (lysine-rich or arginine-rich sequences) to improve solubility. DMSO is used for highly hydrophobic sequences. The reconstituted concentration should be calculated using the COA-stated purity and water content; ignoring water content in a hygroscopic lyophilized peptide leads to systematic underdosing.
FAQ
What is the best Chinese peptide company for research use?
Suppliers that consistently pass independent third-party HPLC and mass spectrometry verification include downstream brands sourcing from GL Biochem (Shanghai) and Scilight Peptide (Beijing). For pharmaceutical-grade API, Hybio Pharmaceutical is the most documented Chinese manufacturer with FDA Drug Master Files. The key differentiator is lot-specific COA documentation with HPLC chromatograms and MS confirmation, not just purity percentages.
How do I verify a Chinese peptide COA is real?
A real COA includes a lot number traceable to the batch, an HPLC chromatogram (not just a purity percentage), a mass spec result matching the theoretical molecular weight, and an endotoxin or sterility result if the peptide is injectable-grade. A percentage alone on a PDF is not a COA.
Are Chinese peptide manufacturers FDA-approved?
Most Chinese peptide manufacturers selling to the US research market are not FDA-approved drug manufacturers. A small number, including Hybio Pharmaceutical, hold FDA Drug Master Files for specific peptide APIs used in licensed pharmaceutical products. Research-grade suppliers operate outside this regulatory framework.
What purity should a research-grade peptide be?
Research-grade peptides are conventionally sold at greater than or equal to 95% purity by HPLC. Pharmaceutical-grade APIs used in licensed drugs typically require greater than 98% purity with full impurity profiling. For any injectable application, endotoxin levels below 1 EU per mg are a minimum standard.
What is GL Biochem and why does it matter?
GL Biochem (Shanghai) is one of the world's largest custom peptide synthesis facilities, supplying both research-grade and pharmaceutical-grade peptides. It is ISO 9001 certified and manufactures for downstream Western resellers. Many US and European peptide brands source from GL Biochem or comparable Shanghai-based CDMO facilities.
What are the main risks of buying peptides from Chinese suppliers?
The main risks are undisclosed impurities from incomplete synthesis or purification, mislabeled sequences, contamination with endotoxins, and regulatory uncertainty at import. Independent mass spectrometry testing is the only reliable way to confirm sequence fidelity. Purity certificates from the same supplier selling the product are not independent verification.
Does Chinese peptide purity labeling differ from USP standards?
Yes. USP monographs for peptide drugs specify assay methods, impurity limits, and reference standards. Chinese domestic standards (ChP) may differ in the HPLC method used, column chemistry, and impurity thresholds. A purity claim made under ChP is not directly comparable to a USP assay result without method bridging.
How should I store peptides from Chinese suppliers?
Lyophilized peptides should be stored at minus 20 degrees Celsius or colder, away from humidity and light. Peptides containing methionine, cysteine, or tryptophan residues are especially prone to oxidative degradation when exposed to air or light during storage. The freeze-dry process removes water but does not eliminate oxidation risk from headspace oxygen.
What is Hybio Pharmaceutical and is it a legitimate source?
Hybio Pharmaceutical (Shenzhen Stock Exchange: 300199) is a publicly listed Chinese company that manufactures peptide APIs for licensed drugs including oxytocin and thymalfasin. It holds FDA Drug Master Files for select APIs and is a legitimate pharmaceutical manufacturer. It does not sell directly to individual researchers.
Can Chinese-manufactured peptides be used in compounding pharmacies?
US compounding pharmacies under 503A or 503B designation must source APIs from FDA-registered facilities or suppliers with appropriate documentation. A Chinese API manufacturer supplying a US compounder must appear on the FDA import alert clearance list or hold a relevant DMF. Using unverified Chinese peptide APIs in a US compounding pharmacy is a regulatory violation.
What is the difference between a CDMO and a research peptide supplier in China?
A Chinese CDMO like GL Biochem produces peptides to customer specifications under quality agreements for pharmaceutical or biotech clients. A research peptide supplier sells catalog or custom peptides to labs and individual buyers with lighter regulatory controls and less stringent quality documentation. The two categories overlap at larger research suppliers.
How do shipping and customs affect peptide quality from China?
Temperature excursions during transit are a real degradation risk, especially for disulfide-bonded or methionine-containing peptides. Lyophilized peptides tolerate short-duration ambient transit better than peptides in solution, but long customs holds at elevated temperatures accelerate degradation in any form.
Sources
- GL Biochem (Shanghai) Ltd. Company quality certifications and ISO 9001 documentation. Available at: glbiochem.com
- Hybio Pharmaceutical Co., Ltd. Annual reports and regulatory filings. Shenzhen Stock Exchange listing: 300199.
- US Food and Drug Administration. Drug Master File database. Available at: fda.gov/drugs/forms-submission-requirements/drug-master-files-dmfs
- US Pharmacopeia. General Chapter on Peptide Mapping and Purity Testing. USP-NF. United States Pharmacopeial Convention.
- International Council for Harmonisation. ICH Q1A(R2): Stability Testing of New Drug Substances and Drug Products. 2003.
- US Food and Drug Administration. Guidance for Industry: Analytical Procedures and Methods Validation for Drugs and Biologics. 2015.
- Merrifield RB. Solid phase peptide synthesis. Journal of the American Chemical Society. 1963;85(14):2149-2154.
- Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annual Review of Biochemistry. 1993;62:797-821. (Basis for methionine and cysteine oxidation chemistry.)
- Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China (ChP). Current edition. Beijing: China Medical Science Press.
- US Food and Drug Administration. Current Good Manufacturing Practice (CGMP) regulations for compounding pharmacies. 21 CFR Parts 210 and 211.
- Scilight Peptide (Beijing). Company profile and custom synthesis documentation. Available at: scilightpeptide.com
- Bachem AG. Company quality and regulatory documentation. Available at: bachem.com